CTI BioPharma Corp. (CTIC)
Jun 26, 2023 - CTIC was delisted (reason: acquired by Sobi)
9.09
0.00 (0.00%)
Inactive · Last trade price
on Jun 23, 2023
CTI BioPharma Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$9.80
Upside
+7.81%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 24, 2023 |
SVB Leerink | SVB Leerink | Buy → Hold Downgrades $13 → $9.1 | Buy → Hold | Downgrades | $13 → $9.1 | +0.11% | May 16, 2023 |
Stifel | Stifel | Strong Buy → Hold Downgrades $8.1 → $9.1 | Strong Buy → Hold | Downgrades | $8.1 → $9.1 | +0.11% | May 15, 2023 |
JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 11, 2023 |
Needham | Needham | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 11, 2023 |
Needham | Needham | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | -0.99% | Apr 19, 2023 |
TD Cowen | TD Cowen | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | -11.99% | Apr 17, 2023 |
JMP Securities | JMP Securities | Buy Reiterates $9 | Buy | Reiterates | $9 | -0.99% | Mar 7, 2023 |
Needham | Needham | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | -0.99% | Mar 6, 2023 |
JMP Securities | JMP Securities | Buy Reiterates $9 | Buy | Reiterates | $9 | -0.99% | Feb 6, 2023 |
SVB Leerink | SVB Leerink | Buy Initiates $13 | Buy | Initiates | $13 | +43.01% | Oct 17, 2022 |
Jefferies | Jefferies | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +43.01% | Sep 1, 2022 |
JMP Securities | JMP Securities | Buy Maintains $6 → $9 | Buy | Maintains | $6 → $9 | -0.99% | Aug 9, 2022 |
Needham | Needham | Strong Buy Maintains $8 → $9 | Strong Buy | Maintains | $8 → $9 | -0.99% | Aug 9, 2022 |
Cowen & Co. | Cowen & Co. | Buy Initiates $10 | Buy | Initiates | $10 | +10.01% | Jul 7, 2022 |
JMP Securities | JMP Securities | Buy Maintains $4 → $5 | Buy | Maintains | $4 → $5 | -44.99% | Mar 2, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.